World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Nestlé Wins Pfizer Auction
Keywords:
Nestle agreed to pay $11.85 billion for Pfizer's infant nutrition business. This business came with Pfizer's $68 billion acquisition of Wyeth Pharmaceutical. Nestle outbid Danone for the deal, paying what analysts say is a 20% premium. The deal was important for Nestle to secure its position in the fast growing infant nutrition business in China. With the acquisition Nestle would have a 9.7% market share in China, after Mead Johnson with 11.7%, and about tied with Danone at 9.8%. Nestle has a 17% share of the $27 billion market worldwide for baby milk formula, followed by Mead Johnson Nutrition with 15% and Danone with 13%, according to Euromonitor International. The deal was important for Nestle because its market share in China was small compared to its rivals- only 2.3%.
Pfizer's animal health and nutrition units
07/08/2011
Grouped Articles
Pfizer Weighs Options for Animal-Health, Nutrition Units
Wall Street Journal 07/08/2011
Pfizer: Spinoff Likely for Animal Health
Wall Street Journal 07/28/2011
Pfizer reportedly to sell division to Nestle
Wall Street Journal 04/18/2012
Nestlé Is Near Deal for Pfizer Infant Unit
Wall Street Journal 04/18/2012
Wall Street Journal 04/24/2012
Pfizer Profit Declines 19% After Loss of Lipitor Patent
New York Times 05/01/2012
Pfizer performance 2010-2015
04/19/2011
Grouped Articles
Pfizer’s Ploy and the Porous Tax Laws
New York Times 05/23/2014
Spurned by AstraZeneca, Pfizer Walks Away
Wall Street Journal 05/27/2014
Pfizer to Buy Hospira for $16 Billion
Wall Street Journal 02/06/2015
Pfizer Bets $15 Billion on New Class of Generic Drugs
New York Times 02/05/2015
Why Allergan Is a Cure for What Ails Pfizer
Wall Street Journal 10/30/2015
Wall Street Journal 04/19/2011
Pfizer strategy and restructuring- 2010-2015
04/08/2009
Grouped Articles
Pfizer to Pursue Bid for AstraZeneca
Wall Street Journal 04/28/2014
In Drug Mergers, There's One Sure Bet: The Layoffs
Wall Street Journal 04/30/2014
Pfizer Outlines Post-Wyeth R&D Structure
Wall Street Journal 04/08/2009
Pfizer’s Ploy and the Porous Tax Laws
New York Times 05/23/2014
Spurned by AstraZeneca, Pfizer Walks Away
Wall Street Journal 05/27/2014
Pfizer to Buy Hospira for $16 Billion
Wall Street Journal 02/06/2015
Pfizer acquisitions and divestments
03/12/2009
Grouped Articles
For Drug Deals, Small Is Beautiful
Wall Street Journal 03/12/2009
Pfizer to Pursue Bid for AstraZeneca
Wall Street Journal 04/28/2014
Pfizer Shouldn't Put Away Its Checkbook
Wall Street Journal 05/05/2014
Pfizer’s Ploy and the Porous Tax Laws
New York Times 05/23/2014
Pfizer to Buy Hospira for $16 Billion
Wall Street Journal 02/06/2015
Pfizer Bets $15 Billion on New Class of Generic Drugs
New York Times 02/05/2015
Pfizer restructuring.
07/31/2006
Grouped Articles
Pfizer to Pursue Bid for AstraZeneca
Wall Street Journal 04/28/2014
In Drug Mergers, There's One Sure Bet: The Layoffs
Wall Street Journal 04/30/2014
Pfizer Outlines Post-Wyeth R&D Structure
Wall Street Journal 04/08/2009
Pfizer's New Chief Faces Several Challenges
Wall Street Journal 07/31/2006
As Drug Industry Struggles, Chemists Face Layoff Wave
Wall Street Journal 12/11/2007
Can Pfizer Deliver a New Prescription?
Wall Street Journal 03/04/2008
Nestle's strategies in China and other emerging markets
04/23/2012
Linked Articles
Wall Street Journal 04/23/2012
Wall Street Journal 04/24/2012
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us